May 2019

FIRST MEDICINAL CANNABIS TRIAL TO TREAT TOURETTE’S SYNDROME BRINGS HOPE TO AUSTRALIAN PATIENTS

Chris Wright, Brisbane local who was diagnosed with Tourette’s syndrome at the age of 12 is one of the first patients recruited for the trial run by Brisbane’s Wesley Medical Research. The trial aims to assess the effects of medicinal cannabis on symptoms such as uncontrollable physical and/or verbal ticks. Read the article here.

Thanks to new streamlined processes, Queensland specialist doctors soon will be able to prescribe medicinal cannabis directly to their patients, meaning the medicine will be treated just like any other prescription drug in Queensland.

READ MORE >

Growing cannabis for medicinal use has a huge potential in Australia. However, due to the nature of the plant, there is still stigma associated with cultivating medicinal cannabis.

READ MORE >

ANTG becomes first Australian member of The Global Cannabis Partnership (GCP), not-for-profit collaboration of leaders in the government-sanctioned cannabis industry. The partnership offers a great opportunity for the company to take part in shaping the future of medicinal cannabis industry.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >